Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 15452

Fort Lauderdale, FL 33308

Study Summary:

A phase IIb dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for introduction of HIV-1 virologic suppression in HIV-1 infected, antiretrovial therapy naive adult subjects.

Qualified Participants Must:

• Be at least 18 years of age
• Have a viral load of equal to or greater than 1000 c/mL
• Have a CD4+ cell count of greater than or equal to 200
• Be ART medication naive of equal to or less than 10 days

Qualified Participants May Receive:

Compensation for time and travel, all medical office visits and study medication.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.